Cardiovascular Risk Assessment and Effects on Behavior in Switzerland The Swiss Heart Foundation

Niclas Freund1, Bernhard C Friedli2, Therese Junker3

  • 1University Hospital Basel, Cardiology Department, Switzerland.

Insights

CardioTest (®) in Swiss pharmacies identified cardiovascular risk and influenced behavior. While overall risk was low, higher risk scores prompted doctor consultations and correlated with increased cardiovascular events.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacy Practice

Background:

  • CardioTest (®) is a tool for assessing cardiovascular risk.
  • The study evaluated its effectiveness in Swiss pharmacies for risk stratification and behavioral impact.

Purpose of the Study:

  • To determine if pharmacy-based CardioTest (®) provides accurate cardiovascular risk stratification.
  • To assess the impact of CardioTest (®) on individual behavior and lifestyle modifications.

Main Methods:

  • Evaluated participants' blood pressure, waist circumference, blood samples, and risk factors.
  • Calculated cardiovascular risk using the AGLA Risk Score (ARS), a modified PROCAM Score.
  • Followed up participants after one year to assess actions taken and cardiovascular events (chest pain, myocardial infarction, stroke).

Main Results:

  • 746 participants (mean age 62.7 years, 60% male) completed the follow-up.
  • The majority had low cardiovascular risk (73.9% ARS <10%), with 21.7% intermediate and 4.4% high (ARS >20%).
  • Higher ARS significantly correlated with increased doctor consultations and a higher rate of cardiovascular events.

Conclusions:

  • Pharmacy-based CardioTest (®) offers risk stratification for future cardiovascular events.
  • The tool appears to influence individual behavior and promote lifestyle changes.
  • Consideration of alternative screening settings may be needed to reach higher-risk individuals earlier.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
720
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
354
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
879
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
605
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K